US$ 21.51
retatrutide microdose Why Are Fit Guys Microdosing GLP-1s? 6 GLP 1 Microdosing SECRETS
Description
Patients with Type 2 diabetes who received GLP-1RAs had an increased risk of gastroparesis diagnosis at six, nine, 12, 18 and 24 months

M.et al (2025)
For context, hair loss has been reported in post-marketing data and UK SmPCs for semaglutide 2.4 mg and tirzepatide, both of which share mechanistic similarities with retatrutide

Deciphering cellular transcriptional alterations in Alzheimers disease brains

This does not mean the Phase 2 weight-loss numbers will hold up

More studies and clinical trials are needed to explore the risk of pancreatitis by each individual available agent of the GLP-1 RA class
